Measure of Engagement of Epilepsy Patients in Messaging Groups

October 11, 2017 updated by: Abbas Hasan, Royal Free Hospital NHS Foundation Trust

Measure of Engagement of Epilepsy Patients in Messaging Groups and Group Characteristics That Influence Engagement.

This study will measure the engagement of people with epilepsy in a mobile phone based messaging platform as well as understand if there is an impact on their self-management

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The primary purpose of this study is to assess a person with epilepsy's level of usage of a mobile messaging application for peer support. The secondary purpose is to understand what characteristics of their group drive different levels of usage and improvements in self-management.

Participants can participate as much or little as they want for a minimum of six weeks. Participants will complete an initial and a final questionnaire.

Study Type

Interventional

Enrollment (Actual)

202

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
      • Lewisham, United Kingdom, SE4 2LA
        • Lewisham & Greenwich NHS Trust
      • London, United Kingdom, WC1N 3BG
        • National Hospital For Neurology and Neurosurgery
      • London, United Kingdom, Nw3 2QG
        • Royal Free Hospital
      • London, United Kingdom, E1 1BB
        • Barts and The London NHS Trust
      • Maidstone, United Kingdom, ME15 7AT
        • Kent Community Health NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age, diagnosis of epilepsy, have access to a smartphone capable of running messaging application

Exclusion Criteria:

  • A diagnosis of learning disability/difficulty, significant mental health conditions; those in care, bereaved, or prisoners. Any other vulnerable individuals (individuals unable to protect themselves against significant harm or exploitation)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
The Experimental Group will be placed in a group using the matching algorithm. Facilitator support and education intervention
Behavioral: Facilitator support and education
Group engaged with facilitator support and education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Engagement
Time Frame: 6 weeks
Average participant number of posts over time frame assessed by tracking number of participant entries
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Epilepsy self-management
Time Frame: Change in Baseline to 6 weeks
Patient activation measure based on self-reported questionnaire
Change in Baseline to 6 weeks
Epilepsy medication adherence
Time Frame: Change in Baseline to 6 weeks
Medication adherence based on self-reported questionnaire
Change in Baseline to 6 weeks
Epilepsy quality of life
Time Frame: Change in Baseline to 6 weeks
Quality of life in epilepsy metric based on self-reported questionnaire
Change in Baseline to 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Royal Free Hospital NHS Foundation Trust

Investigators

  • Principal Investigator: Adina Nash, Royal Free London NHS Foundation Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2016

Primary Completion (Actual)

August 10, 2017

Study Completion (Actual)

August 10, 2017

Study Registration Dates

First Submitted

February 2, 2017

First Submitted That Met QC Criteria

March 6, 2017

First Posted (Actual)

March 10, 2017

Study Record Updates

Last Update Posted (Actual)

October 12, 2017

Last Update Submitted That Met QC Criteria

October 11, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 203594

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No current resource to share individual participant data. Data will be destroyed per protocol after due course and completion of study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epilepsy

Clinical Trials on Facilitator support and education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe